Drug Research and Development-Sci Forschen

Aims and Scope

SCI FORSCHEN has made Journal of Drug Research and Development as an open source so that your articles attract large number of readers worldwide. The journal aims to publish top quality articles which are highly informative and unique and provide immediate free access to the readers for all types of original works. To be published in the Journal of Drug Research and Development by SCI FORSCHEN, the articles need to be of top quality, special importance and broad interest. The manuscripts submitted by the authors undergo several stages of the peer review process so that the high standard of the journal is maintained. The journal providesa broad license to the readers, which enables them to have free online access to all types of original works. The license provides liberty to the authors to make their work as open access and distribute without any permission from the publisher.

The articles to be published in the SCI FORSCHEN journal Journal of Drug Research and Development be appropriate for the Drug Research and Pharmaceutical Technology. Initially Editors-in-Chief check the submitted manuscripts submitted by various authors. The manuscripts are then reviewed by reviewers who are appointed by the editors and are experts in the in the field which the topic of the manuscript is related to. The quality and accuracy of the article is determined by the unbiased peer review process by the reviewers. After peer review, the reviewers provide a review report to the editors and if the reports provide positive result only then the articles are published in the journal. There is no boundation regarding the length of the articles, the authors can submit the article of any number of pages but all the information in it should be important from the reader’s point of view. The authors can track their articles through the editorial tracking system.

SCI FORSCHEN provides a fast publication schedule while maintaining a meticulous peer review process. According to the policy of SCI FORSCHEN, all the articles should be submitted online while the peer review is done in a fully electronic manner in order to take the final decision within 6 weeks from submission of the manuscript. SCI FORSCHEN offer proper space so that the full text is made available to the readers, figures, tables, supplements, colour illustrations and other information regarding the submitted article. For the publication in the journal the article must contain all the important information about the topic, including methods, results, references, description, case studies etc.

The open access publishing provides free access to any internet user in the world, but it is not free for the authors. SCI FORSCHEN charges a very affordable article processing fee from the authors and this fee includes the charges of publication, administration and maintenance of the article. Low fee is charged from the authors from the low and middle income countries. To maintain the integrity and high standards of the articles in the journal SCI FORSCHEN employs a plagiarism detection system to make sure that the manuscript is not copied and is plagiarism free.

This is an open access (OA) journal, which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of "open access."

Subjects covered by The Journal of Drug Research and Development are:

• Cardiovascular biology

• Compound Management

• Cardiovascular biology

• Compound Management

• Metabolomics

• Computational Chemistry

• Bioavailability

• Bioequivalence

• Chemo informatics

• Molecular Modelling

• Molecular Docking

• Clinical Pharmacology

• Computer-assisted Drug Design

• Drug-drug & Drug-Chemical Interactions

• New Molecular Entity

• Orphan Drug

• Pharmacodynamics

• Pharmaceutical Chemistry

• Pharmaceutical Toxicology

• Neuropharmacology

• High throughput Screening

• Medicinal Chemistry

• Pharmacogenomics

• Pharmacognosy

• Pharmacoepidemiology

• Pharmacogenetics

• Overdose

• Pharmacokinetics

• Pharmaceutics

• Posology

• Structure-activity Relationships (SAR)

• Psychopharmacology

• Quantitative structure-activity Relationship

• Simcyp Simulator

• Synthetic Chemistry

• Therapeutic Window

• Pharmacology

• Pharmacophores

• Physiologically-based pharmacokinetic modelling